News & Reports
Jurag Separation presents at Bio-Europe 15-17 Nov 2010
Posted 8. Nov 2010
Jurag Separation will participate in the Bio-Europe partnering event in Munich from Nov 15-17 and do a company presentation on Nov 16, 2010.
First trials using REED for mammalian cell fermentations positive
Posted 15. Oct 2010
ModiQuest (NL) has in collaboration with Jurag conducted small scale lab trials to investigate the effect of using REED in connection with mammalian cell fermentations. Initial trials performed with REED mammalian cell fermentations indicate positive yield effect from connecting REED device to lab scale fermentation. It is the intention to repeat trials on larger scale to verify results.
Jurag builds the first small scale REED prototype targeted at mammalian cell fermentations
Posted May 17 2010
Jurag builds the first prototype for conducting REED trials on mammalian cells. The prototype is targeted at 1-2 liter fermentor scale and it is the intention to test this in collaboration with a partner during 2010.
REED patent granted in the US
Posted April 27, 2010
Jurag's patent: "Method and apparatus for isolation og ionic species from a liquid" has been granted in the US on April 27, 2010. With the patent being granted in the US, it has now been grated in all applied countries world-wide except for Poland, where the process is still ongoing.
cGMP documentation certificate for REED
Posted 7. Dec 2009
NNE Pharmaplan completes review of Jurag's documentation package for cGMP approval and certifies that it complies with cGMP requirements for equipment to be used in the biotech, pharma and food industries. More info
New appointment
Posted 18. nov 2009
Effective as per October 1. 2009 Jurag Separation A/S has appointed Mr. Søren Pedersen as new Managing Director. Søren holds a MSc and an MBA. Søren has latest served as Vice President of Sales and Marketing in Upfront Chromotography. Before this, Søren worked for Novozymes in a six year period and held various senior positions in sales, key account management and product management. Søren will focus on strengthening the pipeline of projects in the application field of Jurag's advanced REED separation technology with collaboration partners from pharmaceutical manufacturing and food ingredients.
During his five years with Jurag, Dr. Heinrich Biehl reached remarkable results. In this period, the REED Technology has succeeded in obtaining significant and promising break-throughs in various industrial fields and segments.
Pharmaceutical Engineering brings article about the REED technology
Posted 1. aug 2009
The article presents electro membrane technology for improving yields of bioreactor processes. More info
Proces-Teknik brings article about the REED technology
Posted 23. sep 2008
The advances of the REED technology for fermentation apllications to appear in Danish speciality paper (The article is in Danish). More info
Jurag Separation removes heavy metal ions from fly ach
Posted 23. maj 2008
An article in Ingeniøren describes Jurag Separations participation in a DTU lead project concerning the removal of heavy metal ions from fly ach. (The article is in Danish). More info
Arne W. Schmidt new member of the Board of Directors
Posted 15. jan 2008
At an extraordinary General Meeting on December 13th, 2007, the shareholders of Jurag Separation elected Mr. Arne W. Schmidt as new member of the Board of Directors with effect from January 1st, 2008.
We are satisfied that Arne Schmidt has agreed to become part of the board allowing us to benefit from his vast experience with complex manufacturing environments as well as his extensive insights into the biotech- and biopharmaceutical industry.
Arne Schmidt has during the past three decades played an integral part in the success of Novo Nordisk A/S and Novozymes A/S. He has recently retired from Novozymes from a position as Executive Vice President with responsibility for Development, Production and Quality and will continue as a consultant for Novozymes. Arne Schmidt holds a bachelors degree in chemical engineering from the Technical University of Denmark. More info
FoodNavigator.com brings article about REED technology
Posted 2. jul 2007
New technology makes better probiotics, claims Chr Hansen.
Ingredient maker Chr Hansen is set to begin large-scale tests on a new technology that could result in more robust and longer lasting probiotic bacteria, the firm announced last week. More info
Chr. Hansen announces collaboration with Jurag Separation
Posted 29. jun 2007
Chr. Hansen?s scientists see interesting potential in new, unique fermentation technology which improves conditions for ?friendly? gut bacteria
Jurag Separation appears in local news paper
Posted 13. jun 2007
Jurag Separation appears in the local news paper - Berlingske - as feature story covering the increasing number of Univercity projects that make commercial success. The article describes the recent license agreement between Chr.Hansen and Jurag Separation in conncetion with the obvious benefits of the REED technology for productivity enhancements of fermentations (Article is in Danish). More info
New appointment
Posted 1. jun 2007
Jurag Separation has hired Ina Jensen as Project chemist to support the increasing number of customer projects.
Ina has masters degree from Department of Food Science, Univercity of Copenhagen, and has worked at Novo Nordisk as process engineer
Chr. Hansen and Jurag Separation enter into licensing agreement
Posted 13. June 2007
The agreement with Chr. Hansen, a leading manufacturer of food ingredients, demonstrates commercial viability of Jurag Separations unique separation system and confirms the technology?s attractiveness for scalable and productive solutions in industrial settings.
With the joint venture Chr. Hansen gets access to Jurag Separations patented REED filtration technology, which offers advanced electro-membrane solutions for separation of ionic species directly from fermentation broth as well as from a variety of other complex process streams.
As improving the yields of fermentations always presents a challenge in many industries Jurag Separation?s REED technology can provide a compelling solution. Consequently, the REED technology is now being assessed for a number of fermentation applications within the pharmaceutical, biotech as well as food ingredient industry.
In a range of ongoing fermentation projects, the REED technology has been verified as a strong and unique separation process, which has improved the performance of these applications with significant increase in production yields.
Chr. Hansen is the leading global manufacturer of food ingredients products including starter cultures for the dairy industry. The licensing agreement with Chr. Hansen sends a clear signal to other industries in terms of sustainability of the REED technology. More info
Vækstfonden transfers shares to Sunstone Capital
Posted 8. maj 2007
Vækstfonden has tranfered its shares in Jurag Separation to Sunstone Captial as part of the establishment of Sunstone Capital. In connection with the transfer Claus Andersson has been elected as new board member representing Sunstone Capital.
Jurag moves to new premises
Posted 1. maj 2006
Jurag Separation moves to new and larger premises in Allerød to support the increasing number of customer enquiries and projects
Bioneer and Jurag Separation enters into license agreement
Posted 25. feb 2006
Bioneer and Jurag Separation enters into license agreement, where Bioneer recieves the rigths to use the REED technology for expression of therapeutic proteins in lactic acid bacteria.